A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 12
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : RXFP
Long Form : relaxin family peptide
No. Year Title Co-occurring Abbreviation
2015 International Union of Basic and Clinical Pharmacology. XCV. Recent advances in the understanding of the pharmacology and biological roles of relaxin family peptide receptors 1-4, the receptors for relaxin family peptides. INSL3
2013 Chimeric RXFP1 and RXFP2 Receptors Highlight the Similar Mechanism of Activation Utilizing Their N-Terminal Low-Density Lipoprotein Class A Modules. LDLa, TM
2013 Relaxin: new pathophysiological aspects and pharmacological perspectives for an old protein. ---
2012 Identification of key residues essential for the structural fold and receptor selectivity within the A-chain of human gene-2 (H2) relaxin. ---
2012 Increased feeding and body weight gain in rats after acute and chronic activation of RXFP3 by relaxin-3 and receptor-selective peptides: functional and therapeutic implications. ---
2012 Relaxin induces matrix-metalloproteinases-9 and -13 via RXFP1: induction of MMP-9 involves the PI3K, ERK, Akt and PKC-zeta pathways. ---
2010 Membrane receptors: structure and function of the relaxin family peptide receptors. GPCRs, INSL3, LDLa, LGRs, LRRs
2010 The relaxin peptide family--structure, function and clinical applications. GPCRs, INSL
2009 Resolving the unconventional mechanisms underlying RXFP1 and RXFP2 receptor function. GPCRs, INSL3, LDL-A, LRRs
10  2008 The A-chain of human relaxin family peptides has distinct roles in the binding and activation of the different relaxin family peptide receptors. GPCRs
11  2007 Relaxin family peptide receptors--former orphans reunite with their parent ligands to activate multiple signalling pathways. INSL
12  2006 The NMR solution structure of the relaxin (RXFP1) receptor lipoprotein receptor class A module and identification of key residues in the N-terminal region of the module that mediate receptor activation. INSL3, LDLa